Literature DB >> 18931678

Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Marc Veldhoen1, Catherine Uyttenhove, Jacques van Snick, Helena Helmby, Astrid Westendorf, Jan Buer, Bruno Martin, Christoph Wilhelm, Brigitta Stockinger.   

Abstract

Since the discovery of T helper type 1 and type 2 effector T cell subsets 20 years ago, inducible regulatory T cells and interleukin 17 (IL-17)-producing T helper cells have been added to the 'portfolio' of helper T cells. It is unclear how many more effector T cell subsets there may be and to what degree their characteristics are fixed or flexible. Here we show that transforming growth factor-beta, a cytokine at the center of the differentiation of IL-17-producing T helper cells and inducible regulatory T cells, 'reprograms' T helper type 2 cells to lose their characteristic profile and switch to IL-9 secretion or, in combination with IL-4, drives the differentiation of 'T(H)-9' cells directly. Thus, transforming growth factor-beta constitutes a regulatory 'switch' that in combination with other cytokines can 'reprogram' effector T cell differentiation along different pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931678     DOI: 10.1038/ni.1659

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  488 in total

Review 1.  Emerging roles of T helper subsets in the pathogenesis of asthma.

Authors:  Douglas M Durrant; Dennis W Metzger
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

Review 2.  Regulation of TH17 cell differentiation by innate immune signals.

Authors:  Gonghua Huang; Yanyan Wang; Hongbo Chi
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

3.  Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells.

Authors:  Wassim Elyaman; Ribal Bassil; Elizabeth M Bradshaw; William Orent; Youmna Lahoud; Bing Zhu; Freddy Radtke; Hideo Yagita; Samia J Khoury
Journal:  Immunity       Date:  2012-04-12       Impact factor: 31.745

Review 4.  Helper T-cell differentiation and plasticity: insights from epigenetics.

Authors:  Kiyoshi Hirahara; Golnaz Vahedi; Kamran Ghoreschi; Xiang-Ping Yang; Shingo Nakayamada; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

5.  [Th9 cells. Functionally important or just an epiphenomenon?].

Authors:  A Ramming; H Schulze-Koops; A Skapenko
Journal:  Z Rheumatol       Date:  2012-07       Impact factor: 1.372

6.  Phenotypes of Th lineages generated by the commonly used activation with anti-CD3/CD28 antibodies differ from those generated by the physiological activation with the specific antigen.

Authors:  Cuiyan Tan; Lai Wei; Barbara P Vistica; Guangpu Shi; Eric F Wawrousek; Igal Gery
Journal:  Cell Mol Immunol       Date:  2014-03-03       Impact factor: 11.530

7.  Inhibition of squamous cancer growth in a mouse model by Staphylococcal enterotoxin B-triggered Th9 cell expansion.

Authors:  Bei-Ping Miao; Rui-Shi Zhang; Huan-Ji Sun; Yan-Ping Yu; Tao Chen; Lin-Jing Li; Jiang-Qi Liu; Jun Liu; Hai-Qiong Yu; Min Zhang; Zhi-Gang Liu; Ping-Chang Yang
Journal:  Cell Mol Immunol       Date:  2015-09-21       Impact factor: 11.530

Review 8.  Signals for the execution of Th2 effector function.

Authors:  Deborah J Fowell
Journal:  Cytokine       Date:  2009-02-23       Impact factor: 3.861

9.  Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity.

Authors:  Christoph Schlapbach; Ahmed Gehad; Chao Yang; Rei Watanabe; Emmanuella Guenova; Jessica E Teague; Laura Campbell; Nikhil Yawalkar; Thomas S Kupper; Rachael A Clark
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

10.  Th9 cell development requires a BATF-regulated transcriptional network.

Authors:  Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.